Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, Qatar University, PO Box 2713,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zolezzi M, Abouelhassan R, Eltorki Y, Haddad PM, Noorizadeh M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/fe95571e0823467983a83e86dafadb3d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe95571e0823467983a83e86dafadb3d
record_format dspace
spelling oai:doaj.org-article:fe95571e0823467983a83e86dafadb3d2021-12-02T17:44:01ZLong-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile1178-2021https://doaj.org/article/fe95571e0823467983a83e86dafadb3d2021-06-01T00:00:00Zhttps://www.dovepress.com/long-acting-injectable-antipsychotics-a-systematic-review-of-their-non-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, Qatar University, PO Box 2713, Doha, QatarEmail mzolezzi@qu.edu.qaIntroduction: Long acting injectable (LAI) antipsychotics are commonly used in the treatment of schizophrenia to improve adherence and clinical outcomes. Concerns have been reported in relation to their non-systemic or injection site adverse effect profile. As such, this study aims to review and evaluate all evidence reporting injection site adverse effects with LAI antipsychotics.Methods: An electronic search was systematically conducted through four databases (PubMed, Embase, SCOPUS, Cochrane) in order to identify studies investigating injection-site reactions associated with LAI antipsychotics. Unpublished studies such as conference proceedings and clinical trial registries were also searched. The search was limited to literature published in English without year limits.Results: Of a total of 189 citations that were identified from the electronic database search, 12 were selected for inclusion in this review. Various injection site reactions were reported in these studies, including pain, bleeding, and swelling. Overall, the studies reported a low incidence of these injection site reactions. Only a minority of the included articles compared injection site reactions between different LAI antipsychotics.Conclusion: Injection site pain was the most commonly reported injection site adverse effect across all articles reviewed. The low incidence of injection site adverse effects associated with LAI antipsychotics indicates that these formulations appear to be well tolerated by patients. More head-to-head trials comparing second generation LAI antipsychotics are needed.Keywords: intramuscular preparations, depot antipsychotics, injection site adverse effectsZolezzi MAbouelhassan REltorki YHaddad PMNoorizadeh MDove Medical Pressarticleintramuscular preparationsdepot antipsychoticsinjection site adverse effectsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 1917-1926 (2021)
institution DOAJ
collection DOAJ
language EN
topic intramuscular preparations
depot antipsychotics
injection site adverse effects
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle intramuscular preparations
depot antipsychotics
injection site adverse effects
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Zolezzi M
Abouelhassan R
Eltorki Y
Haddad PM
Noorizadeh M
Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
description Monica Zolezzi,1 Rawan Abouelhassan,1 Yassin Eltorki,2 Peter M Haddad,2 Mahtab Noorizadeh1 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Mental Health Hospital, Hamad Medical Corporation, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, Qatar University, PO Box 2713, Doha, QatarEmail mzolezzi@qu.edu.qaIntroduction: Long acting injectable (LAI) antipsychotics are commonly used in the treatment of schizophrenia to improve adherence and clinical outcomes. Concerns have been reported in relation to their non-systemic or injection site adverse effect profile. As such, this study aims to review and evaluate all evidence reporting injection site adverse effects with LAI antipsychotics.Methods: An electronic search was systematically conducted through four databases (PubMed, Embase, SCOPUS, Cochrane) in order to identify studies investigating injection-site reactions associated with LAI antipsychotics. Unpublished studies such as conference proceedings and clinical trial registries were also searched. The search was limited to literature published in English without year limits.Results: Of a total of 189 citations that were identified from the electronic database search, 12 were selected for inclusion in this review. Various injection site reactions were reported in these studies, including pain, bleeding, and swelling. Overall, the studies reported a low incidence of these injection site reactions. Only a minority of the included articles compared injection site reactions between different LAI antipsychotics.Conclusion: Injection site pain was the most commonly reported injection site adverse effect across all articles reviewed. The low incidence of injection site adverse effects associated with LAI antipsychotics indicates that these formulations appear to be well tolerated by patients. More head-to-head trials comparing second generation LAI antipsychotics are needed.Keywords: intramuscular preparations, depot antipsychotics, injection site adverse effects
format article
author Zolezzi M
Abouelhassan R
Eltorki Y
Haddad PM
Noorizadeh M
author_facet Zolezzi M
Abouelhassan R
Eltorki Y
Haddad PM
Noorizadeh M
author_sort Zolezzi M
title Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
title_short Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
title_full Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
title_fullStr Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
title_full_unstemmed Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
title_sort long-acting injectable antipsychotics: a systematic review of their non-systemic adverse effect profile
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/fe95571e0823467983a83e86dafadb3d
work_keys_str_mv AT zolezzim longactinginjectableantipsychoticsasystematicreviewoftheirnonsystemicadverseeffectprofile
AT abouelhassanr longactinginjectableantipsychoticsasystematicreviewoftheirnonsystemicadverseeffectprofile
AT eltorkiy longactinginjectableantipsychoticsasystematicreviewoftheirnonsystemicadverseeffectprofile
AT haddadpm longactinginjectableantipsychoticsasystematicreviewoftheirnonsystemicadverseeffectprofile
AT noorizadehm longactinginjectableantipsychoticsasystematicreviewoftheirnonsystemicadverseeffectprofile
_version_ 1718379684110008320